Home Healthcare Pharmaceuticals Spinal Muscular Atrophy Treatment Market

Spinal Muscular Atrophy Treatment Market Size, Share & Trends Analysis Report By SMA Type (Severe (type I, severe SMA or Werdnig-Hoffmann disease), Intermediate (type II or chronic SMA), Mild (type III, juvenile SMA or Kugelberg-Welander disease), Type IV (adult SMA)), By Treatment (Gene Therapy, Drugs, Medication, Physical Therapy, Surgery, Others), By Route of Administration (Oral, Intrathecal, Paranteral), By Drug (Nusinersen, Onasemnogene, Abeparvovec, Others), By Administration (Intrathecal, Intraspinal, Subcutaneous, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By End User (Hospitals, Homecare, Specialty Clinics, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR604DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Spinal Muscular Atrophy Treatment Market Size Analysis
    1. Introduction
    2. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
      1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
      2. Intermediate (type II or chronic SMA)
      3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
      4. Type IV (adult SMA)
    3. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
      1. Gene Therapy
      2. Drugs
      3. Medication
      4. Physical Therapy
      5. Surgery
      6. Others
    4. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Intrathecal
      3. Paranteral
    5. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
      1. Nusinersen
      2. Onasemnogene
      3. Abeparvovec
      4. Others
    6. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
      1. Intrathecal
      2. Intraspinal
      3. Subcutaneous
      4. Others
    7. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    8. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Homecare
      3. Specialty Clinics
      4. Others
  7. North America Spinal Muscular Atrophy Treatment Market Size Analysis
    1. Introduction
    2. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
      1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
      2. Intermediate (type II or chronic SMA)
      3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
      4. Type IV (adult SMA)
    3. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
      1. Gene Therapy
      2. Drugs
      3. Medication
      4. Physical Therapy
      5. Surgery
      6. Others
    4. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Intrathecal
      3. Paranteral
    5. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
      1. Nusinersen
      2. Onasemnogene
      3. Abeparvovec
      4. Others
    6. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
      1. Intrathecal
      2. Intraspinal
      3. Subcutaneous
      4. Others
    7. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    8. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Homecare
      3. Specialty Clinics
      4. Others
    9. U.S.
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    10. Canada
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
  8. Europe Spinal Muscular Atrophy Treatment Market Size Analysis
    1. Introduction
    2. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
      1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
      2. Intermediate (type II or chronic SMA)
      3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
      4. Type IV (adult SMA)
    3. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
      1. Gene Therapy
      2. Drugs
      3. Medication
      4. Physical Therapy
      5. Surgery
      6. Others
    4. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Intrathecal
      3. Paranteral
    5. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
      1. Nusinersen
      2. Onasemnogene
      3. Abeparvovec
      4. Others
    6. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
      1. Intrathecal
      2. Intraspinal
      3. Subcutaneous
      4. Others
    7. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    8. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Homecare
      3. Specialty Clinics
      4. Others
    9. U.K.
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    10. Germany
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    11. France
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    12. Spain
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    13. Italy
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    14. Russia
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    15. Nordic
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    16. Benelux
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    17. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
  9. APAC Spinal Muscular Atrophy Treatment Market Size Analysis
    1. Introduction
    2. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
      1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
      2. Intermediate (type II or chronic SMA)
      3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
      4. Type IV (adult SMA)
    3. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
      1. Gene Therapy
      2. Drugs
      3. Medication
      4. Physical Therapy
      5. Surgery
      6. Others
    4. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Intrathecal
      3. Paranteral
    5. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
      1. Nusinersen
      2. Onasemnogene
      3. Abeparvovec
      4. Others
    6. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
      1. Intrathecal
      2. Intraspinal
      3. Subcutaneous
      4. Others
    7. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    8. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Homecare
      3. Specialty Clinics
      4. Others
    9. China
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    10. Korea
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    11. Japan
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    12. India
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    13. Australia
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    14. Taiwan
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    15. South East Asia
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    16. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
  10. Middle East and Africa Spinal Muscular Atrophy Treatment Market Size Analysis
    1. Introduction
    2. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
      1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
      2. Intermediate (type II or chronic SMA)
      3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
      4. Type IV (adult SMA)
    3. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
      1. Gene Therapy
      2. Drugs
      3. Medication
      4. Physical Therapy
      5. Surgery
      6. Others
    4. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Intrathecal
      3. Paranteral
    5. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
      1. Nusinersen
      2. Onasemnogene
      3. Abeparvovec
      4. Others
    6. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
      1. Intrathecal
      2. Intraspinal
      3. Subcutaneous
      4. Others
    7. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    8. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Homecare
      3. Specialty Clinics
      4. Others
    9. UAE
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    10. Turkey
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    11. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    12. South Africa
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    13. Egypt
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    14. Nigeria
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    15. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
  11. LATAM Spinal Muscular Atrophy Treatment Market Size Analysis
    1. Introduction
    2. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
      1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
      2. Intermediate (type II or chronic SMA)
      3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
      4. Type IV (adult SMA)
    3. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
      1. Gene Therapy
      2. Drugs
      3. Medication
      4. Physical Therapy
      5. Surgery
      6. Others
    4. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Intrathecal
      3. Paranteral
    5. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
      1. Nusinersen
      2. Onasemnogene
      3. Abeparvovec
      4. Others
    6. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
      1. Intrathecal
      2. Intraspinal
      3. Subcutaneous
      4. Others
    7. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    8. Spinal Muscular Atrophy Treatment Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Homecare
      3. Specialty Clinics
      4. Others
    9. Brazil
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    10. Mexico
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    11. Argentina
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    12. Chile
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    13. Colombia
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
    14. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By SMA Type 2022-2034 (USD MILLION/ Units)
        1. Severe (type I, severe SMA or Werdnig-Hoffmann disease)
        2. Intermediate (type II or chronic SMA)
        3. Mild (type III, juvenile SMA or Kugelberg-Welander disease)
        4. Type IV (adult SMA)
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Gene Therapy
        2. Drugs
        3. Medication
        4. Physical Therapy
        5. Surgery
        6. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intrathecal
        3. Paranteral
      5. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Nusinersen
        2. Onasemnogene
        3. Abeparvovec
        4. Others
      6. Market Size & Forecast By Administration 2022-2034 (USD MILLION/ Units)
        1. Intrathecal
        2. Intraspinal
        3. Subcutaneous
        4. Others
      7. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
      8. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Homecare
        3. Specialty Clinics
        4. Others
  12. Competitive Landscape
    1. Spinal Muscular Atrophy Treatment Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Pfizer Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Biogen Idec
    3. Boehringer Ingelheim GmbH
    4. Ionis Pharmaceuticals Inc.
    5. Avexis Inc.
    6. Novartis AG
    7. Cytokinetics Inc.
    8. Hoffmann-La Roche AG
    9. Regeneron Pharmaceuticals Inc.
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.